The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

The Prevalence and Characteristics of Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background Pain

The aim of this study was to assess the prevalence and characteristics of breakthrough cancer pain (BTcP) in patients receiving low doses of opioids for background pain. A consecutive sample of advanced cancer patients receiving less than 60 mg/day of oral morphine equivalent (OME) was selected. Epi...

Full description

Bibliographic Details
Main Authors: Sebastiano Mercadante, Marco Maltoni, Domenico Russo, Claudio Adile, Patrizia Ferrera, Romina Rossi, Marta Rosati, Alessandra Casuccio
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
breakthrough cancer pain
opioids
doses
Online Access:https://www.mdpi.com/2072-6694/13/5/1058

Internet

https://www.mdpi.com/2072-6694/13/5/1058

Similar Items